ArticleHypertension research : official journal of the Japanese Society of Hypertension2019

Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study.

Hiroshi Itoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.